BCAT1
BCAT1proteinBCAT1 (branched-chain amino-acid aminotransferase 1) mediates OXE-R-driven cardioprotection, reducing myocardial ischemic injury in Type 1 MI.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleOXE-R-dependent effector providing myocardial protection and limiting infarction extent.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableNo
EnsemblENSG00000060982
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Oxoeicosanoid receptor inhibition alleviates acute myocardial infarction through activation of BCAT1.Basic research in cardiology · 2021 · PMID 33484341 · doi